310 related articles for article (PubMed ID: 27060277)
1. A new chromogenic medium for isolation of Bacteroides fragilis suitable for screening for strains with antimicrobial resistance.
Tierney D; Copsey SD; Morris T; Perry JD
Anaerobe; 2016 Jun; 39():168-72. PubMed ID: 27060277
[TBL] [Abstract][Full Text] [Related]
2. [Bacteroides fragilis group in non-diarrheal human feces and its antimicrobial susceptibility].
Rodríguez E; Gamboa MM; Rodríguez C; Vargas P
Rev Esp Quimioter; 2006 Dec; 19(4):357-62. PubMed ID: 17235405
[TBL] [Abstract][Full Text] [Related]
3. Antimicrobial susceptibility of clinical isolates of Bacteroides fragilis group organisms recovered from 2009 to 2012 in a Korean hospital.
Yim J; Lee Y; Kim M; Seo YH; Kim WH; Yong D; Jeong SH; Lee K; Chong Y
Ann Lab Med; 2015 Jan; 35(1):94-8. PubMed ID: 25553287
[TBL] [Abstract][Full Text] [Related]
4. Antimicrobial resistance in the Bacteroides fragilis group in faecal samples from patients receiving broad-spectrum antibiotics.
Hansen KCM; Schwensen SAF; Henriksen DP; Justesen US; Sydenham TV
Anaerobe; 2017 Oct; 47():79-85. PubMed ID: 28445776
[TBL] [Abstract][Full Text] [Related]
5. Development of EUCAST disk diffusion method for susceptibility testing of the Bacteroides fragilis group isolates.
Nagy E; Justesen US; Eitel Z; Urbán E;
Anaerobe; 2015 Feb; 31():65-71. PubMed ID: 25464140
[TBL] [Abstract][Full Text] [Related]
6. Fish meal extract bile esculin agar (FMBE) a selective medium for Bacteroides fragilis group.
Beena VK; Rao S; Kotian M; Shivananda PG
Indian J Pathol Microbiol; 1997 Jul; 40(3):361-4. PubMed ID: 9354008
[TBL] [Abstract][Full Text] [Related]
7. Occurrence of enterotoxigenic and nonenterotoxigenic Bacteroides fragilis in calves and evaluation of their antimicrobial susceptibility.
Almeida FS; Nakano V; Avila-Campos MJ
FEMS Microbiol Lett; 2007 Jul; 272(1):15-21. PubMed ID: 17488333
[TBL] [Abstract][Full Text] [Related]
8. A Novel Selective Medium for Isolation of Bacteroides fragilis from Clinical Specimens.
Ho PL; Ho LY; Yau CY; Tong MK; Chow KH
J Clin Microbiol; 2017 Feb; 55(2):384-390. PubMed ID: 27852672
[TBL] [Abstract][Full Text] [Related]
9. Two cases of infections due to multidrug-resistant Bacteroides fragilis group strains.
Katsandri A; Papaparaskevas J; Pantazatou A; Petrikkos GL; Thomopoulos G; Houhoula DP; Avlamis A
J Clin Microbiol; 2006 Sep; 44(9):3465-7. PubMed ID: 16954304
[TBL] [Abstract][Full Text] [Related]
10. Lessons learned from the anaerobe survey: historical perspective and review of the most recent data (2005-2007).
Snydman DR; Jacobus NV; McDermott LA; Golan Y; Hecht DW; Goldstein EJ; Harrell L; Jenkins S; Newton D; Pierson C; Rihs JD; Yu VL; Venezia R; Finegold SM; Rosenblatt JE; Gorbach SL
Clin Infect Dis; 2010 Jan; 50 Suppl 1():S26-33. PubMed ID: 20067390
[TBL] [Abstract][Full Text] [Related]
11. The underappreciated in vitro activity of tedizolid against Bacteroides fragilis species, including strains resistant to metronidazole and carbapenems.
Goldstein EJ; Citron DM; Tyrrell KL; Leoncio ES; Merriam CV
Anaerobe; 2017 Feb; 43():1-3. PubMed ID: 27713022
[TBL] [Abstract][Full Text] [Related]
12. Isolation, identification and antimicrobial susceptibility of Bacteroides fragilis group strains recovered from broiler faeces.
Garcia GD; Carvalho MA; Diniz CG; Marques JL; Nicoli JR; Farias LM
Br Poult Sci; 2012; 53(1):71-6. PubMed ID: 22404807
[TBL] [Abstract][Full Text] [Related]
13. Resistance trends of Bacteroides fragilis group over an 8-year period, 1997-2004, in Korea.
Roh KH; Kim S; Kim CK; Yum JH; Kim MS; Yong D; Lee K; Kim JM; Chong Y
Korean J Lab Med; 2009 Aug; 29(4):293-8. PubMed ID: 19726890
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of VITEK MS, Clin-ToF-II MS, Autof MS 1000 and VITEK 2 ANC card for identification of Bacteroides fragilis group isolates and antimicrobial susceptibilities of these isolates in a Chinese university hospital.
Wang Y; Chen XF; Xie XL; Xiao M; Yang Y; Zhang G; Zhang JJ; Duan SM; Zhang Q; Zhang P; Tsui C; Xu YC
J Microbiol Immunol Infect; 2019 Jun; 52(3):456-464. PubMed ID: 30772212
[TBL] [Abstract][Full Text] [Related]
15. Bacteroides fragilis group: trends in resistance.
Fille M; Mango M; Lechner M; Schaumann R
Curr Microbiol; 2006 Feb; 52(2):153-7. PubMed ID: 16450067
[TBL] [Abstract][Full Text] [Related]
16. Susceptibility trends of Bacteroides fragilis group isolates from Buenos Aires, Argentina.
Fernández Canigia L; Castello L; Di Martino A; Greco G; Legaria MC; Litterio M; Predari SC; Rollet R; Rossetti A; Carloni G; Sarchi MI; Bianchini H
Rev Argent Microbiol; 2007; 39(3):156-60. PubMed ID: 17987852
[TBL] [Abstract][Full Text] [Related]
17. The prevalence of antibiotic resistance genes in Bacteroides fragilis group strains isolated in different European countries.
Eitel Z; Sóki J; Urbán E; Nagy E;
Anaerobe; 2013 Jun; 21():43-9. PubMed ID: 23500457
[TBL] [Abstract][Full Text] [Related]
18. Virulence markers and antimicrobial susceptibility of bacteria of the Bacteroides fragilis group isolated from stool of children with diarrhea in São Paulo, Brazil.
Nakano V; Avila-Campos MJ
Mem Inst Oswaldo Cruz; 2004 May; 99(3):307-12. PubMed ID: 15273805
[TBL] [Abstract][Full Text] [Related]
19. Isolation of metronidazole-resistant Bacteroides fragilis carrying the nimA nitroreductase gene from a patient in Washington State.
Schapiro JM; Gupta R; Stefansson E; Fang FC; Limaye AP
J Clin Microbiol; 2004 Sep; 42(9):4127-9. PubMed ID: 15364999
[TBL] [Abstract][Full Text] [Related]
20. New medium for selection and presumptive identification of the Bacteroides fragilis group.
Livingston SJ; Kominos SD; Yee RB
J Clin Microbiol; 1978 May; 7(5):448-53. PubMed ID: 659574
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
